Description of the eating disorder sample.

<p>*Life time diagnose.</p><p>ED = eating disorders, AN = Anorexia nervosa, BN = Bulimia nervosa, SA = Suicide attempt.</p

Sample description for the eating disorder and control participants.

a<p>Matching variables,</p>b<p>Life time diagnoses,</p>c<p>non significant difference between bipolar disorders type 1 and type 2.</p><p>ED = eating disorders.</p

Characteristics of suicidal behavior in ED patients and controls.

<p>*Odds ratio (OR) were derived from an unconditional logistic model, adjusted for age, gender and educational level.</p><p>ED = eating disorders, AN = Anorexia nervosa, BN = Bulimia nervosa, SA = Suicide attempt, RRRS = Risk Rescue Rating Scale, SIS = Suicide Intent Scale, SSI = Scale for Suicide Ideation.</p

Proportion of antipsychotic polypharmacy compared with monotherapy (n = 1116).

<p>Proportion of antipsychotic polypharmacy compared with monotherapy (n = 1116).</p

The MEmind web application as viewed from an OSX tablet.

<p>The MEmind web application as viewed from an OSX tablet.</p

Antipsychotic doses when use in combination (n = 287).

<p>Antipsychotic doses when use in combination (n = 287).</p

Prevalence of psychiatric disorders (n = 4975).

<p>Prevalence of psychiatric disorders (n = 4975).</p

Age and gender distribution of most common psychiatric disorders (n = 4354).

<p>Age and gender distribution of most common psychiatric disorders (n = 4354).</p

Prescribed Daily Dose (PDD), and the PDD to defined daily dose ratio of antipsychotics (n = 1116).

<p>Prescribed Daily Dose (PDD), and the PDD to defined daily dose ratio of antipsychotics (n = 1116).</p

Antipsychotic monotherapy and polypharmacy according diagnosis (n = 1116).

<p>Antipsychotic monotherapy and polypharmacy according diagnosis (n = 1116).</p